— Know what they know.
Not Investment Advice

JUNS NASDAQ

Jupiter Neurosciences, Inc.
1W: -3.0% 1M: -24.5% 3M: -84.4% YTD: -96.6% 1Y: -98.0%
$2.55
+0.05 (+2.00%)
 
Weekly Expected Move ±11.7%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 29 · $1.2M mcap · 221243 float · 340.39% daily turnover · Short 28% of daily vol

Balance Sheet Trends

Total Assets
$6M +4074.1% ▲
5Y CAGR: +298.4%
Total Liabilities
$2M -65.9% ▼
5Y CAGR: -16.6%
Shareholders Equity
$4M +171.9% ▲
Cash & Investments
$4M +13136.6% ▲
5Y CAGR: +394.4%
Total Debt
$218K -90.3% ▼
5Y CAGR: -29.0%
Net Debt
-$4M -260.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$208K$331K$64K$28K$4M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$208K$331K$64K$28K$4M
Net Receivables$126K$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$216K$124K$5K$261$114K
Total Current Assets$550K$455K$70K$29K$5M
Property, Plant & Equip.$0$209K$162K$116K$70K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$500K$0$0$0$0
Other Non-Current Assets-$500K$4K$4K$4K$1M
Total Non-Current Assets$0$213K$166K$120K$2M
Total Assets$550K$667K$236K$149K$6M
— Liabilities —
Accounts Payable$252K$257K$187K$189K$279K
Short-Term Debt$108K$441K$2M$2M$146K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3M$5M$5M$3M$119K
Total Current Liabilities$4M$6M$7M$6M$2M
Long-Term Debt$0$0$0$107K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$164K$120K$178K$21K
Total Liabilities$4M$6M$7M$6M$2M
— Equity —
Common Stock$627$653$3K$3K$3K
Retained Earnings-$10M-$14M-$19M-$24M-$26M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$4M-$5M-$7M-$6M$4M
Total Liabilities & Equity$550K$667K$236K$149K$6M
— Key Metrics —
Total Debt$108K$651K$2M$2M$218K
Net Debt-$100K$321K$2M$2M-$4M
Total Investments$500K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms